CLINICAL_TRIALS trial_result · 2022-10-07

Clinical Trial Update: A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS) [Phase 4]

Phase 4 trial assessing safety and efficacy of KRN23 in Epidermal Nevus Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Alabama at Birmingham | Conditions: Epidermal Nevus Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2022-10-07